Related Experiment Video
Updated: Aug 15, 2026
07:32
In vitro Induction of Human Dental Pulp Stem Cells Toward Pancreatic Lineages
Published on: September 25, 2021
[Human pancreatic stem cell and diabetes cell therapy]
F Pattou1, J Kerr-Conte, V Gmyr
1Praticien Hospitalio-Universitaire, UPRES 1048 de Université de Lille 2 et Service de Chirurgie Générale et Endocrinienne, Centre Hospitalier et Universitaire de Lille, 1 Place de Verdun-F59037 Lille.
Bulletin De L'Academie Nationale De Medecine
|July 27, 2001
Summary
Researchers identified a potential new source of insulin-producing cells for type 1 diabetes treatment. Human pancreatic ductal cells can be coaxed to become insulin-secreting cells, offering hope for large-scale cell therapy.
Area of Science:
- Endocrinology and Metabolism
- Regenerative Medicine
- Cell Biology
Context:
- Type 1 diabetes treatment faces limitations with current human islet transplantation scalability.
- Adult pancreas contains stem cells capable of proliferation and differentiation.
- In vitro production of homologous insulin-secreting cells is a promising alternative.
Purpose:
- To explore the potential of adult pancreatic ductal cells as a source for insulin-producing cells.
- To reproduce and characterize the in vitro proliferation and organization of ductal epithelial structures.
- To identify and confirm the expression of key differentiation factors in transdifferentiated ductal cells.
Summary:
- Human islet preparations showed in vitro proliferation of ductal epithelial structures.
- Transdifferentiation of exocrine pancreatic preparations yielded a reproducible source of human ductal cells.
- These ductal cells express insulin promoter factor-1 (IPF-1/PDX-1), a crucial transcription factor for endocrine differentiation.
Impact:
- Successful proliferation and differentiation could provide an abundant source of pancreatic stem cells for ex vivo production of insulin-secreting cells.
- This approach may enable autologous cell therapy for type 1 diabetes, eliminating the need for immunosuppression.
- Advances in regenerative medicine for diabetes treatment.
Related Concept Videos
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.